Thrombosis researchHumansHeparinLow-Molecular-WeightMaleFemale
Early outpatient use of low-molecular-weight heparin benefits COVID-19 outcome in association with hospitalization - Lessons learned.
Miika Koskinen, Eeva Ruotsalainen, Mia Wallin, Hilkka Kivelä, Kerstin Carlsson, Jari Petäjä, Eero Hirvensalo, Markku Mäkijärvi, Riitta Lassila, Outpatient LMWH-Covid-19 Study Group
Published: 202610.1016/j.thromres.2025.109555
Abstract
BACKGROUND: Covid-19 and venous thromboembolism (VTE) share risk factors and thrombo-inflammatory pathophysiology. In-hospital low-molecular-weight heparin (LMWH) use improved outcomes. Before vaccinations or available treatments, the Helsinki univer…
Preview only. Read the full abstract at the source